Orthopaedic Product News & Orthopaedic Press Releases | Orthogate Professionals

November 15, 2016 - By Marie Mckinney

Ronda Stryker Insider Sell

Stryker Corp’s director Ronda Stryker sold 18,000 shares of the company in a broker trade dated November 15, 2016. The unloaded shares were sold at the avg market share price of $109.5, for a total stocks unload of $1,971,506. In the last 30 days, she also sold 120,000 shares worth approximately $13,774,564 USD. The probability of this transaction remaining ignored is very low due to its size, with the director presently having ownership of 24.04 million shares — that is 6.24% of the market capitalization of the Company.

November 10, 2016 - By Marie Mckinney

Ronda Stryker Insider Sell

The director of Stryker Corp and corporation’s insider Ronda Stryker unloaded 18,000 shares of the Pinksheet-listed company based on the avg market share price which is $116.1 for each one share. The sold shares had a value of exactly $2,090,374 US Dollars. It seems she is very active lately as in the last month, she silently unloaded additional 132,000 shares of the company, worth $15,140,387 USD. This enormous sell will probably draw attention, as she now has ownership of 6.58% of the market cap of Stryker Corp.

Medtronic (NYSE:MDT) said today that it’s getting into the large joint replacement business, aiming to capitalize on a new bundled payment program at the Centers for Medicare & Medicaid Services.

Montreal, Quebec – Some potentially good news for aging Baby Boomers: researchers believe that they have developed a hip replacement that will last longer and create fewer problems for the people who receive them than those currently in use. The secret? An implant that "tricks" the host bone into remaining alive by mimicking the varying porosity of real bones.

Interestingly, the key factor that distinguishes the new implant is that it’s less rather than more solid than those in current use, while still being just as strong.

Tricking bones into staying alive
Damiano Pasini, the man behind the design of the new hip replacement, points at the pyramid-like shapes visible on its surface.

The 2016 study has 360 pages, 188 tables and figures. Worldwide hip and knee orthopedic surgical Implant markets are poised to achieve significant growth with the aging of the population.

Old people have trouble making their joints last as long as they do. The patient stability and the relief from pain provided by the implant is compelling. The major suppliers are providing implants that are state of the art. Orthopedic reconstructive implants are used to replace joints that have deteriorated. Deterioration may come as a result of aging, disease, osteoarthritis, or injury.

 For more information about this report:http://www.reportsweb.com/hip-and-knee-orthopedic-surgical-implants-market-shares-strategies-and-forecasts-worldwide-2016-to-2022

Ronda Stryker Insider Sell

Ronda Stryker – an informed person in Stryker Corp who right now serves as a director — sold some 18,000 shares of Stryker Corp, with a total value of about nearly USD$ 2,087,950 at average stock price per share of USD$ 116.0. This is not her first insider trade, in the last month, she sold another 126,000 shares worth $14,423,173 USD. The transaction will most probably not remain disregarded as it was significant. Now, Ronda Stryker possess a total of 24.09 million shares or 6.42% of Stryker Corp’s total market capitalization.

A Huntsville doctor at The Orthopaedic Center (TOC) is one of the first to use newly FDA-approved technology to treat certain types of chronic pain.

"We're using a smart electronic signal to stimulate one of the nervous system's structures adjacent to your spine to help control chronic pain," explains Michael Cosgrove, M.D.

Cosgrove is talking about the dorsal root ganglion (DRG), which is where your body regulates pain signals and sensations. TOC is the only North Alabama location patients can go to in order to get this therapy, and Cosgrove surgically implants the St. Jude Medical neurostimulator system, called DRG therapy.